NCT04142242 - Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine in Older Adults Who Received a Primary Vaccination (3 or More Years Earlier) in Study MET49 | Biotech Hunter

Enrollment

471

Participants

Timeline

Start Date

October 4, 2019

Primary Completion Date

April 1, 2020

Study Completion Date

May 25, 2022

Conditions

Meningococcal Infection (Healthy Volunteers)

Interventions

BIOLOGICAL

Meningococcal Polysaccharide (serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine

Pharmaceutical form: Solution for injection; Route of administration: Intramuscular

OTHER

Blood sample

Blood sample for assessment of antibody persistence.

Trial Locations (34)

13760

Investigational Site Number 8400019, Endwell

15401

Investigational Site Number 8400014, Uniontown

21075

Investigational Site Number 8400010, Elkridge

22911

Investigational Site Number 8400004, Charlottesville

27103

Investigational Site Number 8400033, Winston-Salem

27408

Investigational Site Number 8400021, Greensboro

27612

Investigational Site Number 8400012, Raleigh

29464

Investigational Site Number 8400034, Mt. Pleasant

Investigational Site Number 8400036, Mt. Pleasant

29621

Investigational Site Number 8400018, Anderson

32081

Investigational Site Number 8400022, Ponte Vedra

32127

Investigational Site Number 8400032, Port Orange

32205

Investigational Site Number 8400007, Jacksonville

32216

Investigational Site Number 8400015, Jacksonville

32720

Investigational Site Number 8400023, DeLand

33409

Investigational Site Number 8400020, West Palm Beach

33756

Investigational Site Number 8400038, Clearwater

43212

Investigational Site Number 8400011, Columbus

45241

Investigational Site Number 8400035, Cincinnati

45246

Investigational Site Number 8400005, Cincinnati

55423

Investigational Site Number 8400031, Richfield

58104

Investigational Site Number 8400013, Fargo

63141

Investigational Site Number 8400030, St Louis

67114

Investigational Site Number 8400027, Newton

67205

Investigational Site Number 8400017, Wichita

70006

Investigational Site Number 8400016, Metairie

75231

Investigational Site Number 8400024, Dallas

84107

Investigational Site Number 8400002, Salt Lake City

84123

Investigational Site Number 8400001, Murray

85225

Investigational Site Number 8400026, Chandler

92123-1881

Investigational Site Number 8400003, San Diego

06708

Investigational Site Number 8400028, Waterbury

84088-8865

Investigational Site Number 8400025, West Jordan

00981

Investigational Site Number 6300001, San Juan

All Listed Sponsors

lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY